# Incidence of Intracranial Hemorrhage in Glioma Patients With Venous Thromboembolism Converted From LMWH to Apixaban

> **NCT04895553** · — · TERMINATED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 60 (actual)

## Conditions studied

- Glioma, Malignant

## Interventions

- **OTHER:** Observation of ICH and VTE

## Key facts

- **NCT ID:** NCT04895553
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2021-08-01
- **Primary completion:** 2022-08-05
- **Final completion:** 2022-08-05
- **Target enrollment:** 60 (ACTUAL)
- **Why stopped:** lack of funds. Only 1 patient was enrolled
- **Last updated:** 2022-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04895553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04895553, "Incidence of Intracranial Hemorrhage in Glioma Patients With Venous Thromboembolism Converted From LMWH to Apixaban". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04895553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*